181 related articles for article (PubMed ID: 21440529)
1. ERK/MAPK pathways play critical roles in EGFR ligands-induced MMP1 expression.
Park S; Jung HH; Park YH; Ahn JS; Im YH
Biochem Biophys Res Commun; 2011 Apr; 407(4):680-6. PubMed ID: 21440529
[TBL] [Abstract][Full Text] [Related]
2. Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.
Said AH; Hu S; Abutaleb A; Watkins T; Cheng K; Chahdi A; Kuppusamy P; Saxena N; Xie G; Raufman JP
Biochem J; 2017 Feb; 474(5):647-665. PubMed ID: 28008134
[TBL] [Abstract][Full Text] [Related]
3. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
4. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
Lee SY; Shin SJ; Kim HS
Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
[TBL] [Abstract][Full Text] [Related]
5. EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways.
Qiu Q; Yang M; Tsang BK; Gruslin A
Reproduction; 2004 Sep; 128(3):355-63. PubMed ID: 15333786
[TBL] [Abstract][Full Text] [Related]
6. NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells.
Furuhashi S; Sugita H; Takamori H; Horino K; Nakahara O; Okabe H; Miyake K; Tanaka H; Beppu T; Baba H
Int J Oncol; 2012 Mar; 40(3):807-15. PubMed ID: 22025280
[TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells.
Li CC; Yao HT; Cheng FJ; Hsieh YH; Lu CY; Wu CC; Liu KL; Chang JW
Nutr Cancer; 2015; 67(5):771-82. PubMed ID: 25970488
[TBL] [Abstract][Full Text] [Related]
8. Silibinin suppresses EGFR ligand-induced CD44 expression through inhibition of EGFR activity in breast cancer cells.
Kim S; Han J; Kim JS; Kim JH; Choe JH; Yang JH; Nam SJ; Lee JE
Anticancer Res; 2011 Nov; 31(11):3767-73. PubMed ID: 22110198
[TBL] [Abstract][Full Text] [Related]
9. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
10. Additive effects of EGF and IL-1β regulate tumor cell migration and invasion in gastric adenocarcinoma via activation of ERK1/2.
Han J; Xie Y; Lan F; Yu Y; Liu W; Chen J; Zheng F; Ouyang X; Lin X; Lin Y; Huang Q; Wang L; Tan J
Int J Oncol; 2014 Jul; 45(1):291-301. PubMed ID: 24789460
[TBL] [Abstract][Full Text] [Related]
11. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B; Chang CM; Yuan M; McKenna WG; Shu HK
Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
[TBL] [Abstract][Full Text] [Related]
12. Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity.
Cardoso AP; Pinto ML; Pinto AT; Oliveira MI; Pinto MT; Gonçalves R; Relvas JB; Figueiredo C; Seruca R; Mantovani A; Mareel M; Barbosa MA; Oliveira MJ
Oncogene; 2014 Apr; 33(16):2123-33. PubMed ID: 23644655
[TBL] [Abstract][Full Text] [Related]
13. EGFR phosphorylation-dependent formation of cell-cell contacts by Ras/Erks cascade inhibition.
Kang ES; Oh MA; Lee SA; Kim TY; Kim SH; Gotoh N; Kim YN; Lee JW
Biochim Biophys Acta; 2007 Jun; 1773(6):833-43. PubMed ID: 17368581
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways.
Choi SC; Kim SJ; Choi JH; Park CY; Shim WJ; Lim DS
Stem Cells Dev; 2008 Aug; 17(4):725-36. PubMed ID: 18788932
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
Ripple MO; Kalmadi S; Eastman A
Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
[TBL] [Abstract][Full Text] [Related]
16. The EGF receptor-sox2-EGF receptor feedback loop positively regulates the self-renewal of neural precursor cells.
Hu Q; Zhang L; Wen J; Wang S; Li M; Feng R; Yang X; Li L
Stem Cells; 2010 Feb; 28(2):279-86. PubMed ID: 19882665
[TBL] [Abstract][Full Text] [Related]
17. Akt inhibition up-regulates MMP1 through a CCN2-dependent pathway in human dermal fibroblasts.
Bujor AM; Nakerakanti S; Morris E; Hant FN; Trojanowska M
Exp Dermatol; 2010 Apr; 19(4):347-54. PubMed ID: 20201953
[TBL] [Abstract][Full Text] [Related]
18. [EGFR-ERK signaling pathway down-regulates miRNA-145 in lung cancer cells].
Guo YH; Gao FH; Shi J; Yuan HH; Jiang B
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):187-92. PubMed ID: 23879998
[TBL] [Abstract][Full Text] [Related]
19. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA
Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II regulation of TGF-beta in murine mesangial cells involves both PI3 kinase and MAP kinase.
Perlman A; Lawsin LM; Kolachana P; Saji M; Moore J; Ringel MD
Ann Clin Lab Sci; 2004; 34(3):277-86. PubMed ID: 15487702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]